Skip to main content

Advertisement

Table 3 Age-adjusted characteristics of the study population limited to subjects with HbA1c (≤Q3)

From: Association between hemoglobin A1c and carotid atherosclerosis in rural community-dwelling elderly Japanese men

  Total subjects   Low BMI   High BMI  
  HbA 1c level quintiles   HbA 1c level quintiles   HbA 1c level quintiles  
  Q1 (low) Q2 Q3 (high) P Q1 (low) Q2 Q3 (high) P Q1 (low) Q2 Q3 (high) P
No. at risk 190 205 258   103 102 127   87 103 131  
Age, year 70.3 ± 6.3 70.5 ± 7.6 70.3 ± 6.7   71.5 ± 6.7 71.5 ± 8.1 70.2 ± 7.2   68.9 ± 5.6 69.5 ± 6.9 70.4 ± 6.1  
Systolic blood pressure, mmHg 144 147 143 0.187 140 142 140 0.721 149 152 147 0.223
Antihypertensive medication use, % 35.9 30.1 38.9 0.132 27.4 24.8 30.3 0.642 46.1 35.2 47.0 0.144
Body mass index, kg/m2 22.8 23.5 23.1 0.062 20.8 20.9 20.8 0.674 25.1 26.0 25.4 0.008
Current drinker, % 53.1 52.3 51.5 0.942 60.6 50.4 47.4 0.121 43.7 54.1 55.9 0.179
Current smoker, % 20.5 17.6 24.0 0.242 23.8 21.0 29.2 0.334 16.8 14.5 18.7 0.692
Serum triglycerides, mg/dL 97 119 105 0.003 91 101 92 0.284 105 137 117 0.010
Serum HDL-cholesterol, mg/dL 56 54 56 0.319 60 56 58 0.157 51 52 54 0.321
Serum aspartate aminotransferase (AST), IU/L 25 25 24 0.263 26 25 23 0.127 24 26 24 0.322
Glucose-lowering medication use, % 2.1 2.0 1.2 0.699 3.9 3.0 0.8 0.279 0.0 1.0 1.6 0.481
Lipid-lowering medication use, % 3.2 5.9 5.4 0.410 2.9 5.9 4.7 0.589 3.4 5.8 6.1 0.659
History of cardiovascular disease, % 9.5 8.2 12.4 0.302 7.6 4.7 8.9 0.471 12.2 11.8 15.4 0.675
Taking medication for cardiovascular disease, % 7.4 7.3 11.3 0.218 5.6 3.7 8.2 0.354 9.8 10.8 14.0 0.585
Serum creatinine, mg/dL 0.98 0.92 0.92 0.055 1.00 0.93 0.92 0.193 0.96 0.91 0.93 0.334
Glomerular filtration rate (GFR), mL/min/1.73 m2 63.7 67.3 67.5 0.036 62.7 68.4 69.0 0.020 64.8 66.4 66.0 0.792
  1. Age: mean ± standard deviation. Low BMI consists of BMI <23 kg/m2 and high BMI consists of BMI ≥23 kg/m2. P: age-adjusted values of P for the trend. BMI: body mass index.